Abstract
Background (traditional theory) there are general and principle models and calculation formulas for epidemics, mainly the basic reproduction number R0 of a certain epidemic disease such as COVID-19, the newly confirmed number Cn=Rn-1Cn-1, The threshold of herd immunity is (R0-1)/R0.
Innovation theory Based on the fact that there are groups of different tends (that is, different R0 or Rk), a grouping model of epidemiology is proposed, and a complete and detailed calculation formula is given. The basic relationship is that the overall infection numbers of is equal to the sum of the infection number of groups, namely: Rt=∑(fkRk), where fk is the population proportion of each group, and Rk is the basic reproduction number of each groups. Its important application is the grouping strategy in which prevention and control measures are inclined to high-risk groups. The basic relationship is that the basic reproduction number of each group is equal to the product of the control coefficient of its measures and the original basic reproduction number, namely: Rk=ζkR0k. Compared with the traditional strategy of equal treatment, the grouping strategy has the characteristics of high efficiency, low consumption, and low threshold of herd immunity.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This manuscript does not use any funds.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This manuscript belongs to the study of the epidemic development model and does not involve the issue of ethical standards.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
This manuscript does not cite such data.
